Metropolitan Life Insurance Company (MetLife)’s Aurinia Pharmaceuticals AUPH Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,999	Closed	-$40.1K	–	208
2024 Q1	$40.1K	Hold	7,999	–	–	﹤0.01%	1520
2023 Q4	$71.9K	Hold	7,999	–	–	﹤0.01%	1255
2023 Q3	$62.2K	Buy	7,999 +594	+8%	+$5.81K	﹤0.01%	1276
2023 Q2	$71.7K	Hold	7,405	–	–	﹤0.01%	1205
2023 Q1	$81.2K	Sell	7,405 -859	-10%	-$7.57K	﹤0.01%	1115
2022 Q4	$35.7K	Hold	8,264	–	–	﹤0.01%	1685
2022 Q3	$62.1K	Hold	8,264	–	–	﹤0.01%	1308
2022 Q2	$83.1K	Buy	+8,264	New	+$92.4K	﹤0.01%	1177

Other funds holding AUPH

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s AUPH Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2024, closing a stake of 7,999 shares — an estimated $40.1K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AUPH in Q2 2022 and held it in 8 quarters. The position peaked at $83.1K in Q2 2022. 171 funds tracked by Wall St. Rank hold AUPH as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Aurinia Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 7,999 Aurinia Pharmaceuticals shares in Q2 2024, an estimated $40.1K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Aurinia Pharmaceuticals in Q2 2022 and held it in 8 quarters.
Metropolitan Life Insurance Company (MetLife)'s Aurinia Pharmaceuticals position peaked at $83.1K in Q2 2022.
171 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.